74 related articles for article (PubMed ID: 7123951)
1. [Clinical and morphological developmental peculiarities in ovarian myxoadenocarcinoma].
Lenczewski A; Musiatowicz B; Drozdzewicz M; Lotocki W
Wiad Lek; 1982 Jul; 35(9):595-8. PubMed ID: 7123951
[No Abstract] [Full Text] [Related]
2. [Clinical course of the disease in familial and non-familial forms of serous cystadenocarcinoma of the ovary].
Akulenko LV; Nikogosian SO; Zhordaniia KI; Kozachenko VP
Akush Ginekol (Mosk); 1991 Sep; (9):58-60. PubMed ID: 1746703
[TBL] [Abstract][Full Text] [Related]
3. Ovarian carcinoma in identical twins.
Tucker MH; Fryer JA; Saunders DM
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):113-5. PubMed ID: 6958248
[No Abstract] [Full Text] [Related]
4. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
Liu C; Zhao Y; Sun X
Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
[TBL] [Abstract][Full Text] [Related]
5. Clinical challenges and images in GI. Gastric metastases of an ovarian cystadenocarcinoma with psammoma bodies.
Gölder SK; Probst A; Messmann H
Gastroenterology; 2008 Jan; 134(1):19, 372. PubMed ID: 18166345
[No Abstract] [Full Text] [Related]
6. A newly established cel line derived from human ovarian adenocarcinoma.
Sekiguchi M; Sakakibara K; Suzuki T; Motoyama T; Fujii G
Jpn J Exp Med; 1980 Aug; 50(4):283-92. PubMed ID: 7441907
[TBL] [Abstract][Full Text] [Related]
7. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
[TBL] [Abstract][Full Text] [Related]
8. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
[TBL] [Abstract][Full Text] [Related]
9. [Hemangiopericytoma of the sigmoid in combination with a mucinous cystadenocarcinoma of the ovaries].
Guliaev AV; Chepik OF
Vopr Onkol; 1983; 29(2):91-3. PubMed ID: 6836979
[No Abstract] [Full Text] [Related]
10. Serous papillary cystadenocarcinoma of the ovary diagnosed with the ThinPrep Pap Test.
Welch JM; Ciesla MC; Selvaggi SM
Acta Cytol; 2000; 44(6):1122-4. PubMed ID: 11127748
[No Abstract] [Full Text] [Related]
11. [Morphological characteristics of serous ovarian adenocarcinomas after chemotherapy].
Serov SF; Irzhanov SI
Vopr Onkol; 1980; 26(3):37-40. PubMed ID: 7368655
[TBL] [Abstract][Full Text] [Related]
12. [Psammoma bodies in the cervico-vaginal smear. Association with bilateral ovarian carcinoma].
Meniconi R; Izzi M
Pathologica; 1982; 74(1033):691-5. PubMed ID: 7167280
[No Abstract] [Full Text] [Related]
13. Six families prone to ovarian cancer.
Fraumeni JF; Grundy GW; Creagan ET; Everson RB
Cancer; 1975 Aug; 36(2):364-9. PubMed ID: 1157008
[TBL] [Abstract][Full Text] [Related]
14. [Neoplastic associations in gynecology. Considerations on a case].
Pesando PC; Guaschino S; Ricevuti G; Castello A; Zara C
Minerva Ginecol; 1981; 33(2-3):263-70. PubMed ID: 7254658
[No Abstract] [Full Text] [Related]
15. Current issues in the pathology of ovarian cancer.
Rabban JT; Bell DA
J Reprod Med; 2005 Jun; 50(6):467-74. PubMed ID: 16050571
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pathological studies on amylase-producing ovarian cancer].
Matsuda M; Izutsu T; Kagabu T; Nishiya I; Iida H; Kubota T
Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):935-42. PubMed ID: 2414384
[No Abstract] [Full Text] [Related]
17. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
18. [Gangrenous cholecystitis complicated by rectal adenocarcinoma and left ovarian cystadenocarcinoma].
Stavitskiĭ VV; Pozdniakov VV
Khirurgiia (Mosk); 1994 Feb; (2):59-60. PubMed ID: 8028257
[No Abstract] [Full Text] [Related]
19. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas.
Tsao SW; Mok CH; Knapp RC; Oike K; Muto MG; Welch WR; Goodman HM; Sheets EE; Berkowitz RS; Lau CC
Gynecol Oncol; 1993 Jan; 48(1):5-10. PubMed ID: 8423021
[TBL] [Abstract][Full Text] [Related]
20. [Dipeptidyl peptidase IV gene expression in ovarian carcinoma cell lines with various maligant behaviour].
Wang ZM; Lu YK; Han Y; Jiang JY; Yuan XD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Apr; 27(2):205-10. PubMed ID: 15960267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
